Lidija Covic
Affiliations: | Biochemistry | Sackler School of Graduate Biomedical Sciences (Tufts University) |
Area:
BiochemistryGoogle:
"Lidija Covic"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Michael E, Covic L, Kuliopulos A. (2022) Lipopeptide Pepducins as Therapeutic Agents. Methods in Molecular Biology (Clifton, N.J.). 2383: 307-333 |
| Lee JL, Ekambaram P, Carleton NM, et al. (2021) MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer. Molecular Cancer Research : McR |
| Van Doren L, Nguyen N, Garzia C, et al. (2020) Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120315154 |
| McAuley JR, Bailey KM, Ekambaram P, et al. (2019) MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types. Oncogene |
| Kimmelstiel C, Stevenson R, Nguyen N, et al. (2019) Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel. Thrombosis Research. 177: 59-69 |
| Michael ES, Covic L, Kuliopulos A. (2019) Trace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells. Journal of Biological Chemistry. 294: 4401-4411 |
| Van Doren L, Nguyen N, Garzia C, et al. (2019) Blockade of Lipid Receptor GPR31 Suppresses Platelet Reactivity and Thrombosis with Minimal Effect on Hemostasis Blood. 134: 1064-1064 |
| Covic L, Kuliopulos A. (2018) Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach. International Journal of Molecular Sciences. 19: 2237 |
| Rana R, Huang T, Koukos G, et al. (2018) Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology |
| Gurbel PA, Bliden KP, Turner SE, et al. (2015) Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology |